Zhou Jiang
Zhejiang University
8 Papers
11 Citations
Zhou Jiang is an academic researcher from Zhejiang University. The author has contributed to research in topics: Colorectal cancer & Breast cancer. The author has an hindex of 6, co-authored 8 publications.
Chat about Author
Papers
Breast cancer-derived exosomes transmit lncRNA SNHG16 to induce CD73+γδ1 Treg cells.
Chao Ni,Qingqing Fang,Wuzhen Chen,Jin-Xing Jiang,Zhou Jiang,Jun Ye,Ting Zhang,Liu Yang,Fan-Bo Meng,Wenjie Xia,Miaochun Zhong,Jian Huang +11 more
TL;DR: The results first identify the significance of CD73+Vδ1 Tregs in BC, and therapy targeting this subpopulation or blocking TDEs might have potential for BC treatment in the future.
Cross-talk between the gut microbiota and monocyte-like macrophages mediates an inflammatory response to promote colitis-associated tumourigenesis.
Yunben Yang,Lili Li,Chunjing Xu,Yunke Wang,Zhen Wang,Mengyao Chen,Zhou Jiang,Jun Pan,Chenghui Yang,Xiaoqian Li,Kai Song,Junfeng Yan,Wanglan Xie,Xianguo Wu,Zhigang Chen,Ying Yuan,Shu Zheng,Jun Yan,Jian Huang,Fuming Qiu +19 more
TL;DR: The gut microbiota uses LPS as a trigger to regulate MLM accumulation in a chemokine-dependent manner and generate a precancerous inflammatory milieu to facilitate tumourigenesis.
Tumor-derived HMGB1 induces CD62Ldim neutrophil polarization and promotes lung metastasis in triple-negative breast cancer.
Zhen Wang,Chenghui Yang,Lili Li,Xiaoyan Jin,Zhigang Zhang,Haiyan Zheng,Jun Pan,Liyun Shi,Zhou Jiang,Ke Su,Baizhou Li,Xuan Shao,Fuming Qiu,Jun Yan,Jian Huang +14 more
- 17 Sep 2020
TL;DR: The results suggest that the combination of HMGB1 and CD62Ldim neutrophils is a potential marker for breast cancer lung metastasis and is novel target for future prevention and therapy.
Trametes robiniophila Murr: a traditional Chinese medicine with potent anti-tumor effects.
TL;DR: The in vitro and in vivo experiment showed Huaier directly inhibited tumor cell proliferation, induced tumor cell death, prevented metastasis and interfered with angiogenesis via various signaling pathways.
LYRM2 directly regulates complex I activity to support tumor growth in colorectal cancer by oxidative phosphorylation.
Qi Huang,Zhigang Chen,Pu Cheng,Zhou Jiang,Zhen Wang,Yucheng Huang,Chenghui Yang,Jun Pan,Fuming Qiu,Jian Huang +9 more
TL;DR: It is found that LYR motif containing 2 (LYRM2), a novel molecule, is up-regulated in colorectal cancer and promotes tumor growth both in vivo and in vitro, and a new Akt-S58phos-LY RM2-Complex I axis is identified, which is responsible for the LYRM2-induced tumor growth and the activation of OXPHOS in colorescopy cancer.
35